Additional Listing and Direct

RNS Number : 2074H

Plant Health Care PLC

16 February 2010

 



Plant Health Care plc

Tuesday, 16 February 2010

PLANT HEALTH CARE plc (THE "COMPANY")

Additional Listing and Directors' Shareholdings

On 15 February, the Company approved the allotment of 24,880 ordinary shares of 1p ("Ordinary Shares") to the following current non-executive directors, in accordance with the Company's existing contractual arrangements, which comprise part of the non-executive directors' remuneration packages and are payable in lieu of a part of their fees.  The shares were allotted at 211p per share, calculated at the closing middle market price derived from the Daily Official List on 15 February 2010. 

Non-executive director	Value of remuneration used to purchase shares	Number of Ordinary Shares allotted
Albert Fischer	£12,500	5,924
Sam Wauchope	£10,000	4,739
David Buckeridge	£10,000	4,739
Dominik Koechlin	£10,000	4,739
Jeremy Scudamore	£10,000	4,739
	TOTAL:	24,880

Following the above-mentioned allotments, the beneficial interests of the non-executive directors in the enlarged Ordinary Share capital of the Company are as shown below:

Name	Ordinary Share holding	Percentage of enlarged Ordinary Share capital	Share Options
Albert Fischer	159,620	0.30	225,000
Sam Wauchope	77,767	0.15	N/A
David Buckeridge	79,702	0.15	N/A
Dominik Koechlin	126,605	0.24	N/A
Jeremy Scudamore	52,201	0.10	N/A

Application has been made for 24,880 Ordinary Shares (the 'New Shares') to be admitted to trading on AIM and admission is expected to occur on 22 February 2010.  The New Shares will rank pari passu with the Company's existing Ordinary Shares. 

Following admission of the New Shares, the total issued share capital of the Company will be 52,711,373 Ordinary Shares, all of which have voting rights. 

The above figure (52,711,373) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules.  

-: Ends :-

Enquiries:

Andrew C. Wood FCIS

Company Secretary                                              

020 8866 5702

Evolution Securities Limited                                Tavistock Communications

Tim Worlledge/Tim Redfern                                     Jeremy Carey/Matt Ridsdale

Tel: [phone]                                                 Tel: [phone]

 

END

 

 

MSCLLFVIFEIRLII